SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-22-017001
Filing Date
2022-11-09
Accepted
2022-11-09 07:03:20
Documents
64
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 6-K tmb-20220930x6k.htm 6-K 24366
2 EX-99.1 tmb-20220930xex99d1.htm   iXBRL EX-99.1 910735
3 EX-99.2 tmb-20220930xex99d2.htm EX-99.2 516922
  Complete submission text file 0001558370-22-017001.txt   4337509

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20220930.xsd EX-101.SCH 51903
5 EX-101.CAL tmb-20220930_cal.xml EX-101.CAL 44658
6 EX-101.DEF tmb-20220930_def.xml EX-101.DEF 133412
7 EX-101.LAB tmb-20220930_lab.xml EX-101.LAB 312225
8 EX-101.PRE tmb-20220930_pre.xml EX-101.PRE 230163
58 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220930xex99d1_htm.xml XML 509610
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 221370612
SIC: 2834 Pharmaceutical Preparations